Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/286,846external-prioritypatent/US5877016A/en
Priority claimed from US08/359,705external-prioritypatent/US5844092A/en
Application filed by Genentech IncfiledCriticalGenentech Inc
Publication of NZ501161ApublicationCriticalpatent/NZ501161A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The specification describes the use of a polypeptide comprising the second immunoglobulin-like domain of a human trkA sequence joined an immunoglobulin amino acid sequence to treat hyperalgesia.
NZ501161A1994-03-181995-03-17Chimeric human trkA-IgG polypeptides which bind to human nerve growth factor.
NZ501161A
(en)